These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 28787724

  • 1. Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
    Harding K, Mersha TB, Webb FA, Vassalotti JA, Nicholas SB.
    Am J Nephrol; 2017; 46(2):156-164. PubMed ID: 28787724
    [Abstract] [Full Text] [Related]

  • 2. Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans.
    Harding K, Mersha TB, Vassalotti JA, Webb FA, Nicholas SB.
    Am J Nephrol; 2017; 46(2):176-186. PubMed ID: 28787720
    [Abstract] [Full Text] [Related]

  • 3. Health Disparities in Kidney Transplantation for African Americans.
    Harding K, Mersha TB, Pham PT, Waterman AD, Webb FA, Vassalotti JA, Nicholas SB.
    Am J Nephrol; 2017; 46(2):165-175. PubMed ID: 28787713
    [Abstract] [Full Text] [Related]

  • 4. Genetics and ESKD Disparities in African Americans.
    Umeukeje EM, Young BA.
    Am J Kidney Dis; 2019 Dec; 74(6):811-821. PubMed ID: 31606237
    [Abstract] [Full Text] [Related]

  • 5. African-Americans with End Stage Renal Disease in the Early Years of Kidney Transplantation.
    Wang JY, Lederer SE, Ross LF.
    J Natl Med Assoc; 2019 Aug; 111(4):352-362. PubMed ID: 30777381
    [Abstract] [Full Text] [Related]

  • 6. Dialysis facility staff perceptions of racial, gender, and age disparities in access to renal transplantation.
    Lipford KJ, McPherson L, Hamoda R, Browne T, Gander JC, Pastan SO, Patzer RE.
    BMC Nephrol; 2018 Jan 10; 19(1):5. PubMed ID: 29316901
    [Abstract] [Full Text] [Related]

  • 7. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.
    Lertdumrongluk P, Streja E, Rhee CM, Moradi H, Chang Y, Reddy U, Tantisattamo E, Kalantar-Zadeh K, Kopp JB.
    Cardiorenal Med; 2019 Jan 10; 9(4):212-221. PubMed ID: 30995638
    [Abstract] [Full Text] [Related]

  • 8. The RaDIANT community study protocol: community-based participatory research for reducing disparities in access to kidney transplantation.
    Patzer RE, Gander J, Sauls L, Amamoo MA, Krisher J, Mulloy LL, Gibney E, Browne T, Plantinga L, Pastan SO, Southeastern Kidney Transplant Coalition.
    BMC Nephrol; 2014 Oct 28; 15():171. PubMed ID: 25348614
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
    Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W, APOL1 Stakeholders Project.
    Am J Nephrol; 2019 Oct 28; 50(4):303-311. PubMed ID: 31480040
    [Abstract] [Full Text] [Related]

  • 10. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
    Devlin A, Waikar SS, Solomon DH, Lu B, Shaykevich T, Alarcón GS, Winkelmayer WC, Costenbader KH.
    Arthritis Care Res (Hoboken); 2011 Dec 28; 63(12):1642-53. PubMed ID: 22058067
    [Abstract] [Full Text] [Related]

  • 11. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.
    Am J Kidney Dis; 2015 Oct 28; 66(4):630-7. PubMed ID: 26002293
    [Abstract] [Full Text] [Related]

  • 12. Effect of education on racial disparities in access to kidney transplantation.
    Goldfarb-Rumyantzev AS, Sandhu GS, Baird B, Barenbaum A, Yoon JH, Dimitri N, Koford JK, Shihab F.
    Clin Transplant; 2012 Oct 28; 26(1):74-81. PubMed ID: 21198857
    [Abstract] [Full Text] [Related]

  • 13. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
    Langefeld CD, Comeau ME, Ng MCY, Guan M, Dimitrov L, Mudgal P, Spainhour MH, Julian BA, Edberg JC, Croker JA, Divers J, Hicks PJ, Bowden DW, Chan GC, Ma L, Palmer ND, Kimberly RP, Freedman BI.
    Kidney Int; 2018 Sep 28; 94(3):599-607. PubMed ID: 29885931
    [Abstract] [Full Text] [Related]

  • 14. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW, Freedman BI.
    Kidney Int; 2011 Dec 28; 80(12):1339-43. PubMed ID: 21849968
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A complex culturally targeted intervention to reduce Hispanic disparities in living kidney donor transplantation: an effectiveness-implementation hybrid study protocol.
    Gordon EJ, Lee J, Kang RH, Caicedo JC, Holl JL, Ladner DP, Shumate MD.
    BMC Health Serv Res; 2018 May 16; 18(1):368. PubMed ID: 29769080
    [Abstract] [Full Text] [Related]

  • 19. Race, Ethnicity, and End-of-Life Care in Dialysis Patients in the United States.
    Foley RN, Sexton DJ, Drawz P, Ishani A, Reule S.
    J Am Soc Nephrol; 2018 Sep 16; 29(9):2387-2399. PubMed ID: 30093455
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.